Antifungal

(redirected from Antifungals)
Also found in: Dictionary, Thesaurus, Medical.

Antifungal

 

a medicinal preparation used to treat such fungal diseases as dermatomycoses, onychomycoses, and candidiasis. Externally, antifungals are applied locally to the focus of the infection in the form of ointments, solutions, and other medicines. They are used to remove skin epidermis, hair, and nails infected by a fungus (salicylic and lactic acid preparations). Other antifungals suppress fungal growth (Amicazol [Asterol Dihydrochloride], Zincundan, and Nitrofungin). Systemic antifungals either kill fungi or inhibit their reproduction when taken orally (griseofulvin, nystatin, Levorin) or when injected intravenously (amphotericin B).

References in periodicals archive ?
Highlights - The global market for human antifungal therapeutics reached nearly $11.
The antifungal market is currently estimated at over 6 billion dollars annually and is growing steadily year on year.
Antifungal therapy should be continued for 2 weeks after the last positive culture and signs of infection have resolved.
Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.
Since 1990, when over-the-counter antifungal medications for yeast vaginitis became available, "we've seen sky rocketing sales of these agents" despite multiple studies showing very poor accuracy of self-diagnosing the condition, he said.
His knowledge and experience in the antifungal sector will be a considerable asset to F2G and I look forward to working with him towards the further development of F2G's antifungal programs.
Overall, those patients who stopped their antifungal therapy had a CD4 T-cell count of 287/ [micro]L and had a viral load of 200 RNA copies/mL, Dr.
The in vitro susceptibility test results confirmed the resistance of the isolate against amphotericin B and fluconazole and nearly all of the few other antifungal agents available for systemic therapy.
The report explores the competitive landscape including top companies benchmarking and the key trend analysis on Mergers and Acquisitions (M&As) and licensing agreements involving antifungals therapies are also presented.
GBI Research analysis shows that the R&D pipeline for the antifungals market is not strong as it has become a generic market.
Nevertheless, "our findings along with others suggest high rates of misdiagnosis and overuse of antifungal mediation by women for other conditions," he concluded.